Objective: To describe the differences in demographics, treatment choice and clinical course of Juvenile Idiopathic Arthritis patients managed at a single Australian tertiary centre over long duration follow-up out to 10 and 20 years.
Methods: A retrospective review was performed for all patients newly diagnosed with Juvenile Idiopathic Arthritis in Canberra since 1985 to present. Key data for inclusion: patient characteristics, disease features (phenotypic diagnosis), history of treatment (including use of conventional and biologic disease modifying anti-rheumatic drugs), outcome measures including remission, duration of follow up.
Results: Data collection and analysis in progress